Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000902219-21-000302
Filing Date
2021-02-04
Accepted
2021-02-04 11:42:35
Documents
1

Document Format Files

Seq Description Document Type Size
1 SEC SCHEDULE 13G SEC13G_Filing.htm SC 13G/A 30988
  Complete submission text file 0000902219-21-000302.txt   32901
Mailing Address C/O WELLINGTON MANAGEMENT COMPANY LLP 280 CONGRESS STREET BOSTON MA 02210
Business Address C/O WELLINGTON MANAGEMENT COMPANY LLP 280 CONGRESS STREET BOSTON MA 02210 6179515000
WELLINGTON MANAGEMENT GROUP LLP (Filed by) CIK: 0000902219 (see all company filings)

EIN.: 042683227 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 0000

Mailing Address 7000 MARINA BLVD BRISBANE CA 94005
Business Address 7000 MARINA BLVD BRISBANE CA 94005 5109706000
SANGAMO THERAPEUTICS, INC (Subject) CIK: 0001001233 (see all company filings)

EIN.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-59049 | Film No.: 21589857
SIC: 2836 Biological Products, (No Diagnostic Substances)